NLS Pharmaceutics Analyst Ratings
BenzingaSep 14, 2023 19:58
NLS Pharmaceutics (NLSP) Receives a Buy From Maxim Group
TipRanksJun 16, 2023 02:55
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Fate Therapeutics (FATE) and NLS Pharmaceutics (NLSP)
TipRanksMay 4, 2023 19:32
Maxim Group Sticks to Their Buy Rating for NLS Pharmaceutics (NLSP)
TipRanksMar 29, 2023 02:56
Maxim Group Keeps Their Buy Rating on NLS Pharmaceutics (NLSP)
TipRanksFeb 1, 2023 01:20
Maxim Group Reaffirms Their Buy Rating on NLS Pharmaceutics (NLSP)
TipRanksJan 25, 2023 01:30
NLS Pharmaceutics Analyst Ratings
Benzinga Analyst RatingsDec 8, 2022 21:42
Maxim Group Upgrades NLS Pharmaceutics to Buy, Announces $4 Price Target
Benzinga Real-time NewsDec 8, 2022 21:42
NLS Pharmaceutics Analyst Ratings
Benzinga Analyst RatingsNov 8, 2022 22:02
No Data
No Data